Advertisement

Physician's First Watch

Physician's First Watch

Medical news from NEJM Journal Watch

December 22, 2014

By The Editors

As of January 2015, over 250,000 providers will have their Medicare payments cut by 1% for failing to meet certain goals for...

Comments (0)

By Amy Orciari Herman

Edited by André Sofair, MD, MPH

The FDA on Friday approved a new, all-oral, interferon-free treatment for patients with hepatitis C genotype 1, including those with cirrhosis. Viekira Pak includes a combination ombitasvir/paritaprevir/ritonavir tablet (two tablets taken once daily) plus a dasabuvir tablet...

Comments (0)

By Amy Orciari Herman

Edited by André Sofair, MD, MPH

The FDA has approved olaparib capsules (brand name, Lynparza) — a poly ADP-ribose polymerase inhibitor — to...

Comments (0)

By Amy Orciari Herman

Edited by André Sofair, MD, MPH

The FDA has approved Zerbaxa — a combination of the new cephalosporin ceftolozane plus the beta-lactamase...

Comments (0)

By Amy Orciari Herman

Edited by André Sofair, MD, MPH

Haruko Obokata, the embattled stem cell researcher whose Nature papers were retracted earlier this year, has resigned after being unable...

Comments (0)

By Amy Orciari Herman

Edited by André Sofair, MD, MPH

The CDC and FDA are investigating a multistate outbreak of listeriosis linked to commercially produced, prepackaged caramel apples. As of Friday,...

Comments (0)

December 19, 2014

By Amy Orciari Herman

Edited by André Sofair, MD, MPH, and William E. Chavey, MD, MS

Latanoprost helps maintain visual field function in patients with open-angle glaucoma, according to an industry-supported study in the Lancet....

Comments (0)

By The Editors

NEJM Group offers so many valuable resources for practicing clinicians. Here's what we chose for you today:

NEJM Knowledge+ Blog: What is patient...

Comments (0)

By The Editors

The CDC's flu surveillance report in MMWR notes that influenza activity has been increasing in recent weeks:

  • As of Dec....

Comments (0)

Pages